Matthew B. Murphy, General Counsel at Nautilus Biotechnology, Inc. (NAUT), bought 5,000 shares at $7.56 ($38K) on 2021-08-13, disclosed to the SEC on 2021-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |